Detalhe da pesquisa
1.
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Mol Carcinog
; 58(12): 2306-2315, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31545001
2.
Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).
Cancers (Basel)
; 16(11)2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38893184
3.
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry.
Biomedicines
; 11(12)2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137396
4.
6q deletion is frequent but unrelated to patient prognosis in breast cancer.
Breast Cancer
; 29(2): 216-223, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625909
5.
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.
J Clin Oncol
; 37(17): 1490-1498, 2019 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31042410
6.
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Aging (Albany NY)
; 11(18): 7796-7804, 2019 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31533087
7.
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.
Oncotarget
; 7(49): 81322-81331, 2016 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27835607